Recent news
November 2010
Groups launch preventive AIDS vaccine trial
November 9, 2010 --
The International AIDS Vaccine Initiative (IAVI) recently announced the launch of a Phase I trial of two preventive AIDS vaccine candidates. The trial, called B003/IPCAVD-004, is the first to test these vaccine candidates in a regimen in which vaccines are given sequentially to boost immune system responses. The trial could eventually involve as many as six clinical research centers in the United States and Africa.
The trial is a joint effort of IAVI; the Beth Israel Deaconess Medical Center; the HIV Vaccine Trials Network; the National Institute of Allergy and Infectious Diseases’ Division of AIDS; the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University; and the biopharmaceutical company Crucell. See the link below for more details.
